PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. Driving scale in a slow-moving healthcare ecosystem is not just a challenge for cell and gene therapies.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Pharma Marketing Network

MARCH 30, 2023

Mary brings to the HBA 30 years of experience leading the strategic integration of corporate branding, marketing, health equity, inclusion, and digital innovation for biopharma, healthcare, and media companies. Morgan Healthcare Conference.

Healthcare 52

Healthcare Healthcare Biopharma Leads 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. The post Leading speciality pharmacies in pharma appeared first on Pharmaceutical Technology.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharma Marketing Network

JANUARY 12, 2023

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Clarivate

APRIL 18, 2024

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52

Retail Healthcare Healthcare Physicians 52

PM360

SEPTEMBER 18, 2024

Varady has spent the last 20 years leading integrated marketing campaigns for biotech and healthcare companies in both U.S. His experience leading large-scale agency accounts for top 10 biopharma companies has led to the successful commercialization of products across a wide array of therapeutic categories.

Marketing 52

Marketing Media Healthcare Healthcare 52

Pharmaceutical Technology

JUNE 4, 2023

Encoded Therapeutics develops gene therapies for the treatment of severe genetic disorders.

Pharmaceutical 105

Pharmaceutical Leads Biopharma Engineering 105

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128

Pharmaceutical Technology

APRIL 20, 2023

CBC CEO Fu Wei stated: “Hasten is a well-established Chinese biopharma company with tremendous growth potential. Hasten will also use the proceeds from the round to fund future acquisitions. The firm reported 47% growth in sales from Q2 to Q4 in 2022, which is testament to CBC’s unique and effective investor-operator strategy.

Biopharma 98

Biopharma Healthcare Healthcare Sales 98

Clarivate

JULY 31, 2023

Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. To learn more about the Dialog platform, visit: here.

Healthcare 52

Healthcare Healthcare Safety Competition 52

PM360

JULY 18, 2022

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore. and Europe.

Biopharma 96

Biopharma Management Marketing Leads 96

PM360

SEPTEMBER 21, 2023

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs. But this change can be doable.

Marketing 105

Marketing Media CRM Sales 105

MedCity News

SEPTEMBER 21, 2023

This article explores the benefits of implementing RFID in healthcare settings and how hospitals can gradually transition from barcode to RFID-enabled medication systems, leading to substantial cost savings and improved patient care.

Medical 105

Medical Healthcare Healthcare Leads 105

Pharmaceutical Technology

MAY 5, 2023

Hasten Biopharmaceutic has purchased the commercial rights for Rocephin in mainland China from Swiss healthcare firm Roche. Hasten Biopharma CEO Summer Xia stated: “Hasten is committed to building a leading innovative medical and healthcare enterprise in China.

Biopharma 52

Biopharma Healthcare Healthcare Leads 52

Clarivate

AUGUST 17, 2022

Grace tells us about her experience as a physician and discusses healthcare literacy and education at the point of care. The post Improving patient access and healthcare literacy [PODCAST] appeared first on Clarivate. You can listen to the podcast now or read the rest of the transcript here.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

pharmaphorum

NOVEMBER 18, 2022

Biopharma’s digital interactions with healthcare professionals (HCPs) are now a critical part of industry relationships. How would you describe the current state of HCP engagement amongst biopharmas? The biggest driver of omnichannel success is meeting HCPs’ preferences for more hybrid, on-demand access to their biopharma reps.

Biopharma 96

Biopharma Leads Engineering Consulting 96

pharmaphorum

JANUARY 11, 2023

Last year, digital health ventures registered a total of 575 regulatory filings around the world, with the medical diagnostics cluster – diagnostic tools, medical imaging, and omics-related analyses – leading the charge with 12% of the total. Roche tops biopharma partnering podium.

Biopharma 74

Biopharma Specialization Physicians Healthcare 74

PM360

MAY 2, 2023

Ardelis Health , a healthcare strategic marketing agency and consulting firm partnering with innovators that discover, differentiate, and launch important therapies, today announced the appointment of industry veteran Timmy Garde as Chief Growth Officer. “We I’m excited to join Ardelis and lead the next phase of our growth,” said Garde.

Food and Drug Administration 52

Food and Drug Administration Healthcare Healthcare Marketing 52

PM360

NOVEMBER 12, 2024

One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. healthcare system over $800 billion annually. Ultimately, women’s healthcare needs are unique and demand tailored solutions. Today, the urgency has never been more apparent.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Healthcare Healthcare 52

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 is to acquire the 2015-established Amryt Pharma Plc. on 6 th January.

Pharma 90

Pharma Biopharma Management Medicine 90

European Pharmaceutical Review

AUGUST 22, 2022

THE GLOBAL outbreak of the COVID-19 pandemic triggered an urgent need to protect people’s lives and livelihoods and the healthcare community recognised quite early that vaccines were the best solution to this crisis. The biopharma sector has witnessed significant transformations in recent times.

Manufacturing 98

Manufacturing Biopharma Engineering Safety 98

pharmaphorum

SEPTEMBER 28, 2022

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52

PM360

JUNE 30, 2022

It includes companies Vynamic, Research Partnership, Putnam Associates, and STEM Healthcare. Inizio Medical: By combining complex scientific understanding with creativity, Inizio Medical promises to create compelling content and engage communities across the spectrum of healthcare.

Specialization 97

Specialization Medical Healthcare Healthcare 97

Clarivate

AUGUST 7, 2024

The pricing estimates are not guaranteed, leading to potential unexpected expenses. The reliance on AWP and MAC, which often exceed actual pharmacy costs, may lead to higher expenses for plan sponsors. Click here to learn more about how Clarivate helps biopharma companies navigate market access across global markets.

Retail 59

Retail Marketing Biopharma Competition 59

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 99

Marketing Sales Medical Patients 99

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. Those of us in the biopharma industry know how fraught drug development can be. As the saying goes, they are individually rare but collectively common. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? Let’s talk about continuous biopharma manufacturing. Speaking of your biopharma clients, what are you hearing about their main priorities? I believe this is going to be an emerging trend in the market.

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Legacy MEDSearch

MAY 19, 2023

Through this collaboration, healthcare providers are able to access clinically relevant heart rhythm analyses and actionable reports via PaceMateLIVE to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and drive improvements to patient care and clinical outcomes.

Healthcare Provider 52

Healthcare Provider Management Healthcare Healthcare 52

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

Marketing 52

Marketing Education Healthcare Healthcare 52

Impetus Digital

MARCH 15, 2024

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

Recruitment 79

Recruitment Healthcare Provider Patients Healthcare 79

pharmaphorum

JANUARY 6, 2023

Emerging and mid-sized companies launching products in Europe are also navigating a healthcare ecosystem that is complex and fragile due to regulatory and cost pressures. With an early view of market viability, leading companies will be able to monetise new products quickly and at scale across Europe.”.

Safety 109

Safety Management Patients Training 109

PM360

SEPTEMBER 30, 2024

And yet drugs remain the most cost-effective part of the healthcare system because they help keep people out of nursing homes and expensive hospital care. Clearly, more needs to be done to align the 80% level of reimbursement for drugs, compared to the 90% plus level of reimbursement for hospital care.

Biopharma 52

Biopharma Patients Marketing Healthcare 52

PM360

OCTOBER 22, 2024

DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. Support healthcare providers in a real and personal way.

Education 52

Education Side effects Medical Patients 52

PM360

AUGUST 24, 2023

As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry. To be sure, steps have been taken.

Competition 98

Competition Marketing Healthcare Healthcare 98

PM360

AUGUST 26, 2024

Fortune 500s or Start-Ups; what are the opportunities and challenges for top school business graduates to consider for the Healthcare/Pharma/Biotech vertical? A: (Galeota) MIT Sloan’s and all MIT students should consider the tremendous career opportunities that the Healthcare/Pharma/Biotech vertical offers.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52